News + Font Resize -

Sigvaris appoints NovoMed as its exclusive distributor in India
Our Bureau, Mumbai | Friday, April 25, 2014, 15:45 Hrs  [IST]

Leading medical device company and pioneer in compression garments including hosiery and socks Sigvaris appointed NovoMed Incorporation Pvt. Ltd. exclusively as its distribution partners in India.

Sigvaris is the world’s leading manufacturer of graduated compression stockings which are clinically proven in the treatment of Deep Vein Thrombosis (DVT), varicose veins, help improve circulation and revive tired, achy legs.

DVT is a clot that develops in the peripheral veins of the limbs. It is often a precursor to a potentially fatal condition known as Pulmonary Embolism (PE) where the blood clot in the peripheral circulation breaks loose, travels to the lungs, lodges in the circulatory system and compromises heart and lung function.

Speaking about the association, Nainesh Mehta, managing director, NovoMed Incorporation Pvt Ltd, said, “We are proud to associate with Sigvaris which has attained global presence and recognition by staying true to their values of perfection, quality and precision.”

DVT today is a widespread problem associated with mortality rates that are higher than those of breast cancer and HIV combined. It affects the following groups of people like Diabetics, those exposed to prolonged periods of immobilization ( Flying / Driving / Sitting ), those who are suffering sports related or traumatic injuries, pregnant women, cancer, women on oral contraceptives or hormone replacement therapy, positive history of DVT or pulmonary embolism, obese individuals, smokers and people above the age of 60 years.

Sigvaris stockings are made available all over India by NovoMed Incorporation Pvt. Ltd.

Sigvaris is recognised as a global industry leader in the area of compression therapy for the management of chronic venous disorders. NovoMed caters to the vascular, cardiovascular, interventional radiology, general surgical, bariatric and specialty medical device market.

Post Your Comment

 

Enquiry Form